门静脉癌栓累及范围与肝功能分级的相关性分析

Clinical analysis of different types of portal carcinocus embolus with liver function change

目的:探讨原发性肝癌合并门静脉一级及二级分支癌栓(PVTT)患者,经肝动脉化疗栓塞术(TACE)治疗前后肝功能分级变化特点。方法:回顾分析254例原发性肝癌病例,根据门静脉有无癌栓及癌栓累及范围分A、B、C 3组,总结TACE治疗后肝功能分级变化的特点。结果:门静脉无癌栓83例(A组);癌栓累及门静脉一级分支39例(B组)、癌栓累及门静脉二级分支64例(C组)。TACE术后3组肝功能分级变化有差异。结论:TACE影响原发性肝癌合并门静脉二级分支癌栓病例治疗前后肝功能分级。

Objective： To analyse primary hepatocellular carcinoma with tumor thrombi in portal vein branch at level I and II patients＇s liver function change before and after transcatheter arterial chemoembolization treatments. Methods： retrospective 254 cases of patients with primary liver cancer,according to tumor thrombi in portal vein tumor thrombus-tree involving the scope of group A、B、C.sum up classification changes of liver function after TACE treatment. Results： without tumor thrombus（group A） 83 cases;tumor thrombus involving the branching at the Portal level 39 cases（Group B）,tumor thrombus involving secondary branch of Portal vein 64 cases A and B groups＇ liver function have not significantly different before and after TACE;fliver function haven changes between the groups A、B and C. Conclusion： TACE affect primary hepatocellular carcinoma with Portal vein tumor thrombosis liver function＇s classification.